share_log

Needham Maintains Buy on Revolution Medicines, Raises Price Target to $46

Moomoo 24/7 ·  Apr 12 06:15

Needham analyst Ami Fadia maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $36 to $46.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment